14 results
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #indications #pharmacology ... #table
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Clinical Disease ... Indication: Individuals ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... please refer to Table ... 5 for dosing recommendation ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... won’t have any clinical ... #Pharmacology #
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
for Preventing ... weeks or until clinically ... with ARV (see Table ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Acceptable Indications for Indwelling Urinary Catheter Use
 • Clinically significant urinary retention - Temporary relief
IDSA Acceptable ... Indications for ... Catheter Use • Clinically ... or incontinence pads ... Catheter #Foley #Management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Management during ... Management during ... Delivery • Stable ... Management during ... months before 1° prevention
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... Primary Infection Indications ... , 2 doses (0.5 mL ... #management #opportunistic ... infections #HIVAIDS #pharmacology